A data review and analysis of women 50 – 59 years old with hysterectomy during that period of time, revealed a 79% decline in estrogen replacement.
Although the data used involved only women with “surgically induced” menopause, research findings suggest that estrogen therapy in younger postmenopausal women (50-59 years old) plays a decisive role in decreasing all-cause mortality, with the greatest reduction in heart attack and breast cancer related deaths.
Click here to go to the article.